(Q43960579)

28 November 2017

title

Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients (English)

1 reference

28 November 2017

0 references

1

1 reference

28 November 2017

6

John H Krystal

1 reference

28 November 2017

Steven M Southwick

2

1 reference

28 November 2017

Ismene L Petrakis

series ordinal

3

1 reference

28 November 2017

Thomas R Kosten

series ordinal

4

1 reference

28 November 2017

Dennis S Charney

series ordinal

5

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

28 November 2017

published in

Biological Psychiatry

1 reference

28 November 2017

volume

51

1 reference

28 November 2017

issue

8

1 reference

28 November 2017

page(s)

642-651

1 reference

Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Desipramine treatment of cocaine dependence in methadone-maintained patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Treatment of cocaine abuse with mazindol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Clonidine use and abuse among methadone program applicants and patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Iontophoretic application of opiates to the locus coeruleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Abstinent opiate abusers exhibit conditioned craving, conditioned withdrawal and reductions in both through extinction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

3-Methoxy-4-hydroxyphenethylene glycol in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Cocaine abuse treatment. Open pilot trial with desipramine and lithium carbonate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Clonidine is not a useful adjunct to methadone gradual detoxification in opioid addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Naltrexone, opiate addiction, and endorphins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Clonidine in acute opiate withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Clonidine blocks acute opiate-withdrawal symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Chronic morphine administration increases the apparent number of α2-adrenergic receptors in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Dose Dependent Effects of Yohimbine on Methadone Maintained Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Effects of naloxone-HCl on cortisol levels in patients with affective disorder and normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Metyrapone-induced withdrawal symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Noradrenergic neurons: morphine inhibition of spontaneous activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Chronic use of opioids and antipsychotic drugs: side effects, effects on endogenous opioids, and toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Drug dependence: stress and dysregulation of brain reward pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Circadian rhythms and levels of beta-endorphin, ACTH, and cortisol during chronic methadone maintenance treatment in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Evidence of acoustic startle hyperreflexia in recently detoxified early onset male alcoholics: modulation by yohimbine and m-chlorophenylpiperazine (mCPP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Drug-induced mood changes in man. I. Observations on healthy subjects, chronically ill patients, and postaddicts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Hypersensitivity to noradrenaline in cortex after chronic morphine: relevance to tolerance and dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Increase in desipramine serum levels associated with methadone treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

The determination of a brain arteriovenous difference for 3-methoxy-4-hydroxyphenethyleneglycol (MHPG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Physiological parameters of morphine dependence in man—Tolerance, early abstinence, protracted abstinence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Yohimbine-facilitated acoustic startle reflex in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Naloxone effects on ?-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Molecular and cellular mechanisms of opiate action: studies in the rat locus coeruleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Assessment of opioid dependence with naloxone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Opiates and opioid peptides hyperpolarize locus coeruleus neurons in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Identification of 5-hydroxytryptamine1D binding sites in human brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Altered plasma cortisol response in patients on methadone maintenance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Reliability of sequential naloxone challenge tests.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

The effect of gamma-hydroxybutyric acid on naloxone-precipitated opiate withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Heterogeneity of psychiatric diagnosis in treated opiate addicts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Should protracted withdrawal from drugs be included in DSM-IV?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Abnormal noradrenergic function in posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Research diagnostic criteria: rationale and reliability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Yohimbine co-treatment during chronic morphine administration attenuates naloxone-precipitated withdrawal without diminishing tail-flick analgesia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Naloxone Increases ACTH and Cortisol Levels in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

Clonidine versus methadone for opiate detoxification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901292-6

10.1016/S0006-3223(01)01292-6

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference